{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:34:24Z","timestamp":1784547264207,"version":"3.55.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ajog.2018.05.017","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:15:27Z","timestamp":1527167727000},"page":"326-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Perinatal anxiety: approach to diagnosis and management in the obstetric\u00a0setting"],"prefix":"10.1016","volume":"219","author":[{"given":"Katie R.","family":"Thorsness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2018.05.017_bib1","first-page":"12","article-title":"Understanding pregnancy anxiety: concepts, correlates and consequences","author":"Guardino","year":"2014","journal-title":"Zero to Three"},{"key":"10.1016\/j.ajog.2018.05.017_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1471-6712.2003.00095.x","article-title":"Women\u2019s worries during pregnancy: testing the Cambridge worry scale on 200 Swedish women","volume":"17","author":"Ohman","year":"2003","journal-title":"Scand J Caring Sci"},{"key":"10.1016\/j.ajog.2018.05.017_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/1471-2458-9-490","article-title":"A\u00a0survey on worries of pregnant women: testing the German version of the Cambridge worry scale","volume":"9","author":"Peterson","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2015.01.039","article-title":"Pregnancy anxiety: a systematic review of current scales","volume":"176","author":"Brunton","year":"2015","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ajog.2018.05.017_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3109\/14767058.2013.858242","article-title":"Obstetric and neonatal outcome in patients with anxiety disorders","volume":"27","author":"Pavlov","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/AOG.0000000000001902","article-title":"Consensus bundle on maternal mental health: perinatal depression and anxiety","volume":"129","author":"Kendig","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib7","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.ajog.2018.05.017_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1037\/0278-6133.27.2.194","article-title":"Racial differences in birth outcomes: the role of general pregnancy and racism stress","volume":"27","author":"Dominguez","year":"2008","journal-title":"Health Psychol"},{"key":"10.1016\/j.ajog.2018.05.017_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10995-005-0048-9","article-title":"Correlates of early postpartum depressive symptoms","volume":"10","author":"Howell","year":"2006","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ajog.2018.05.017_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.annepidem.2005.08.004","article-title":"Racial disparities in elevated prenatal depressive symptoms among black and white women in eastern North Carolina","volume":"16","author":"Orr","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2018.05.017_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/02646830600643908","article-title":"Race\/ethnicity and perinatal depressed mood","volume":"24","author":"Segre","year":"2006","journal-title":"J\u00a0Reprod Infant Psychol"},{"key":"10.1016\/j.ajog.2018.05.017_bib12","first-page":"1","article-title":"Births: Final Data for 2016","volume":"67","author":"Martin","year":"2018","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2018.05.017_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.janxdis.2004.04.001","article-title":"Anxiety symptoms and disorders at eight weeks postpartum","volume":"19","author":"Wenzel","year":"2005","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.ajog.2018.05.017_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/jwh.2013.4438","article-title":"Postpartum anxiety and comorbid depression in a population-based sample of women","volume":"23","author":"Farr","year":"2014","journal-title":"J\u00a0Women Health (Larchmt)"},{"key":"10.1016\/j.ajog.2018.05.017_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/01674820802604839","article-title":"The role of maternal anxiety in the early postpartum period: screening for anxiety and depressive symptomatology in Greece","volume":"30","author":"Giakoumaki","year":"2009","journal-title":"J\u00a0Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00737-016-0704-7","article-title":"The prevalence and incidence of perinatal anxiety disorders among women experiencing a medically complicated pregnancy","volume":"20","author":"Fairbrother","year":"2017","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12884-018-1666-8","article-title":"Anxiety, depression and relationship satisfaction in the pregnancy following stillbirth and after the birth of a live-born baby: a prospective study","volume":"18","author":"Gravensteen","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2018.05.017_bib18","first-page":"975","article-title":"Postpartum depression on the neonatal intensive care unit: current perspectives","volume":"6","author":"Tahirkheli","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2014.02.027","article-title":"Maternal anxiety during pregnancy and adverse birth outcomes: a systematic review and meta-analysis of prospective cohort studies","volume":"159","author":"Ding","year":"2014","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ajog.2018.05.017_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajog.2014.06.042","article-title":"Effects of stress and depression on inflammatory immune parameters in pregnancy","volume":"211","author":"Christian","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ajog.2009.07.041","article-title":"Psychosocial stress during pregnancy","volume":"202","author":"Woods","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1192\/bjp.180.6.502","article-title":"Maternal antenatal anxiety and children\u2019s behavioural\/emotional problems at 4 years: report from the Avon Longitudinal Study of parents and children","volume":"180","author":"O\u2019Connor","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/1469-7610.00187","article-title":"Maternal antenatal anxiety and children\u2019s behavioural\/emotional problems in children: a test of programming hypothesis","volume":"44","author":"O\u2019Connor","year":"2003","journal-title":"J\u00a0Child Psychol Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1207\/s15327078in0603_1","article-title":"Prenatal maternal anxiety and depression predict negative behavioral reactivity in infancy","volume":"6","author":"Davis","year":"2004","journal-title":"Infancy"},{"key":"10.1016\/j.ajog.2018.05.017_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0749-3797(18)30268-X","article-title":"Psychosocial stressors and low birthweight in an urban population","volume":"12","author":"Orr","year":"1996","journal-title":"Am J Prev Med"},{"issue":"5suppl2","key":"10.1016\/j.ajog.2018.05.017_bib26","article-title":"Role of psychosocial and nutritional stress on poor pregnancy outcome","volume":"133","author":"Hobel","year":"2003","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.ajog.2018.05.017_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00737-009-0126-x","article-title":"An open trial with cognitive behavioral therapy for blood-and injection phobia in pregnant women-a group intervention program","volume":"13","author":"Lilliecreutz","year":"2010","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/aje\/kwp061","article-title":"Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones","volume":"169","author":"Kramer","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2018.05.017_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.318.7177.153","article-title":"Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study","volume":"318","author":"Teixeira","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.017_bib30","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0002-9378(93)90016-C","article-title":"The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation","volume":"169","author":"Wadhwa","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ajh.2008.366","article-title":"Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy","volume":"22","author":"Qui","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2018.05.017_bib32","first-page":"487","article-title":"Depression and anxiety in early pregnancy and risk for preeclampsia","volume":"95","author":"Kurki","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000327017","article-title":"Exposure to prenatal psychobiological stress exerts programming influences on the mother and her fetus","volume":"95","author":"Sandman","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ajog.2018.05.017_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1176\/appi.ajp.2012.11091365","article-title":"Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating","volume":"169","author":"Hunter","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1469-7610.2010.02314.x","article-title":"Prenatal maternal stress programs infant stress regulation","volume":"52","author":"Davis","year":"2011","journal-title":"J\u00a0Child Psychol Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib36","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/00004583-200212000-00019","article-title":"Alspac Study Team. Antenatal anxiety predicts child behavioral\/emotional problems independently of postnatal depression","volume":"41","author":"O\u2019Connor","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psyneuen.2009.07.010","article-title":"High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6-9 year-old children","volume":"35","author":"Buss","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2018.05.017_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpsychores.2013.02.008","article-title":"The effects of maternal major depression, generalized anxiety disorder and panic disorder on birth weight and gestational age: a comparative study","volume":"75","author":"Uguz","year":"2013","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.ajog.2018.05.017_bib39","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/01.AOG.0000465192.34779.dc","article-title":"Screening for perinatal depression: Committee Opinion No. 630","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11920-008-0053-y","article-title":"Anxiety disorders in pregnancy","volume":"10","author":"Vythilingum","year":"2008","journal-title":"Curr Psychiatr Rep"},{"key":"10.1016\/j.ajog.2018.05.017_bib41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4088\/JCP.v67n0818","article-title":"Anxiety disorders during pregnancy and the postpartum period: a systematic review","volume":"67","author":"Ross","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jpsychores.2014.03.011","article-title":"Perinatal depression screening; let\u2019s not throw the baby out with the bath water!","volume":"76","author":"Chaudron","year":"2014","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.ajog.2018.05.017_bib43","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1552-6909.2011.01294.x","article-title":"Postpartum obsessive-compulsive disorder","volume":"40","author":"Speisman","year":"2011","journal-title":"J\u00a0Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.ajog.2018.05.017_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jad.2012.12.022","article-title":"Comparison of four self-report measures and a generic mood question to screen for anxiety during pregnancy in English-speaking women","volume":"148","author":"Matthey","year":"2013","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ajog.2018.05.017_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/OGX.0000000000000477","article-title":"It is time for routine screening for perinatal mood and anxiety disorders in obstetrics and gynecology settings","volume":"72","author":"Accortt","year":"2017","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2018.05.017_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1176\/appi.ajp.2008.08121899","article-title":"Postpartum psychosis: detection of risk and management","volume":"166","author":"Spinelli","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib47","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/AOG.0000000000002160","article-title":"Committee Opinion No. 705: mental health disorders in adolescents","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib48","first-page":"140","article-title":"Presidential Task Force on redefining the postpartum visit committee on obstetric practice optimizing postpartum care","volume":"131","author":"Stuebe","year":"2018","journal-title":"Am Coll Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/0167482X.2012.728649","article-title":"Strategies for improving perinatal depression treatment in North American outpatient obstetric settings","volume":"33","author":"Byatt","year":"2012","journal-title":"J\u00a0Psychosom Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib50","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/AOG.0000000000000231","article-title":"Improving care for depression in obstetrics and gynecology: a randomized controlled trial","volume":"123","author":"Melville","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.genhosppsych.2016.03.002","article-title":"Improving perinatal depression care: the Massachusetts child psychiatry access project for moms","volume":"40","author":"Byatt","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2013.08.007","article-title":"Complementary and alternative medicine therapies for perinatal depression","volume":"28","author":"Deligiannidis","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/da.22268","article-title":"Effects of antenatal yoga on maternal anxiety and depression: a randomized controlled trial","volume":"31","author":"Newham","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.ajog.2018.05.017_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JPN.0b013e31823f565b","article-title":"Relaxation during pregnancy: what are the benefits for mother, fetus, and the newborn? A systematic review of the literature","volume":"26","author":"Fink","year":"2012","journal-title":"J\u00a0Perinat Neonatal Nurs"},{"key":"10.1016\/j.ajog.2018.05.017_bib55","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jad.2013.03.005","article-title":"Internet-based behavioral activation: treatment for postnatal depression (Netmums): a randomized controlled trial","volume":"150","author":"O\u2019Mahen","year":"2013","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.ajog.2018.05.017_bib56","first-page":"1","article-title":"Netmums: a phase II randomized controlled trial of a guided internet behavioural activation treatment for postpartum depression","volume":"23","author":"O\u2019Mahen","year":"2013","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00737-015-0586-0","article-title":"Supplement use by women during pregnancy: data from the Massachusetts General Hospital national pregnancy registry for atypical antipsychotics","volume":"19","author":"Freeman","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib58","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/AOG.0b013e3181ba0632","article-title":"The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists","volume":"114","author":"Yonkers","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib59","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archpsyc.57.11.1039","article-title":"Efficacy of interpersonal psychotherapy for postpartum depression","volume":"57","author":"O\u2019Hara","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib60","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/070674379203700905","article-title":"Cognitive-behavioural treatment of panic disorder during pregnancy and lactation","volume":"37","author":"Robinson","year":"1992","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12884-014-0369-z","article-title":"Antenatal mindfulness intervention to reduce depression, anxiety and stress: a pilot randomised controlled trial of the MindBabyBody program in an Australian tertiary maternity hospital","volume":"14","author":"Woolhouse","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2018.05.017_bib62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00737-013-0402-7","article-title":"CALM Pregnancy: results of a pilot study of mindfulness-based cognitive therapy for perinatal anxiety","volume":"17","author":"Goodman","year":"2014","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00737-015-0498-z","article-title":"Cognitive-behavioral group treatment for perinatal anxiety: a pilot study","volume":"18","author":"Green","year":"2015","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0149186","article-title":"A\u00a0randomised controlled trial of Therapist-Assisted, Internet-delivered Cognitive Behavior Therapy for women with maternal depression","volume":"11","author":"Pugh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib65","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cpr.2011.03.009","article-title":"A\u00a0meta-analysis of treatments for perinatal depression","volume":"31","author":"Sockol","year":"2011","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.ajog.2018.05.017_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0447.2009.01490.x","article-title":"A\u00a0register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health","volume":"121","author":"Warburton","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ajog.2018.05.017_bib67","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.v69n0419","article-title":"Changes in antidepressant metabolism and dosing across pregnancy and early postpartum","volume":"69","author":"Sit","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib68","unstructured":"Nonacs R. Prenatal SSRI exposure and speech\/language disorders: many headlines, little risk [online database]. Massachusetts General Hospital Center for Women's Mental health. Available at: https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.2594. Published October 21, 2016. Accessed January 30, 2018."},{"key":"10.1016\/j.ajog.2018.05.017_bib69","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1176\/appi.ajp.2010.09060880","article-title":"Illness risk following rapid versus gradual discontinuation of antidepressants","volume":"167","author":"Baldessarini","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-clinpsy-032813-153626","article-title":"Antidepressant use in pregnant and postpartum women","volume":"10","author":"Yonkers","year":"2014","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.ajog.2018.05.017_bib71","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamapsychiatry.2013.684","article-title":"Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis","volume":"70","author":"Ross","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ppe.12160","article-title":"Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage: assessing potential biases","volume":"29","author":"Johansen","year":"2015","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.ajog.2018.05.017_bib73","doi-asserted-by":"crossref","first-page":"e72095","DOI":"10.1371\/journal.pone.0072095","article-title":"Prenatal antidepressant exposure and risk of spontaneous abortion: a population-based study","volume":"8","author":"Kjaersgaard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib74","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamapsychiatry.2013.684","article-title":"Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis","volume":"70","author":"Ross","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib75","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1176\/appi.ajp.157.12.1933","article-title":"Risk-benefit decision-making for treatment of depression during pregnancy","volume":"157","author":"Wisner","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","article-title":"Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes","volume":"166","author":"Wisner","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib77","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib78","doi-asserted-by":"crossref","first-page":"f4877","DOI":"10.1136\/bmj.f4877","article-title":"Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States","volume":"347","author":"Palmsten","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.017_bib79","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/JCP.0000000000000036","article-title":"Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study","volume":"34","author":"Lupattelli","year":"2014","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib80","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JCP.0b013e318166c52e","article-title":"The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants","volume":"28","author":"Salkeld","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib81","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00737-016-0655-z","article-title":"Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy","volume":"19","author":"De O\u2019Campo","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2125.2012.04196.x","article-title":"Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension","volume":"74","author":"DeVera","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib83","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1176\/appi.ajp.2008.08060817","article-title":"Selective serotonin reuptake inhibitor use and risk of gestational hypertension","volume":"166","author":"Toh","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib84","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/AOG.0000000000000447","article-title":"Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage","volume":"124","author":"Andersen","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1176\/appi.ajp.2012.11081251","article-title":"Use of SSRIS during pregnancy was not associated with increased risk for stillbirth or neonatal mortality","volume":"170","author":"Jimenez-Solem","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2012.153812","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality","volume":"309","author":"Stephensson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2018.05.017_bib87","doi-asserted-by":"crossref","first-page":"49.e1","DOI":"10.1016\/j.ajog.2012.04.028","article-title":"Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies","volume":"207","author":"Hayes","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib88","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib89","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/070674371005501000","article-title":"Association between antidepressant use during pregnancy and infants born small for gestational age","volume":"55","author":"Ramos","year":"2010","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib90","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/AOG.0b013e31816fd910","article-title":"Use of psychiatric medications during pregnancy and lactation. ACOG Practice Bulletin No. 92","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib91","doi-asserted-by":"crossref","first-page":"392778","DOI":"10.1371\/journal.pone.0092778","article-title":"Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis","volume":"9","author":"Huybrechts","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.genhosppsych.2013.08.002","article-title":"A\u00a0meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight","volume":"36","author":"Huang","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib93","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/1471-0528.14144","article-title":"Selective serotonin reuptake inhibitor use during pregnancy and risk for preterm birth: a systematic review and meta-analysis","volume":"123","author":"Eke","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.05.017_bib94","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archgenpsychiatry.2011.2333","article-title":"Maternal use of selective serotonin reuptake inhibitors, fetal growth and risk of adverse birth outcomes","volume":"69","author":"Marroun","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib95","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ije\/dyv351","article-title":"Selective serotonin reuptake inhibitor use during pregnancy: association with offspring birth size and gestational age","volume":"45","author":"Viktorin","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2018.05.017_bib96","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.20773","article-title":"Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy","volume":"91","author":"Colvin","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2018.05.017_bib97","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archpediatrics.2009.164","article-title":"Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes","volume":"163","author":"Lund","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib98","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1471-0528.2007.01518.x","article-title":"Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study","volume":"115","author":"Maschi","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.05.017_bib99","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","article-title":"Selective serotonin reuptake inhibitors and adverse pregnancy outcomes","volume":"194","author":"Wen","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib100","doi-asserted-by":"crossref","first-page":"e0168115","DOI":"10.1371\/journal.pone.0168115","article-title":"Is the risk of preterm birth and low birth weight affected by the use of antidepressant agents during pregnancy? a population based investigation","volume":"11","author":"Cantarutti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib101","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1365-2125.2012.04468.x","article-title":"Antidepressant use and gestational hypertension: does evidence support causality?","volume":"75","author":"Grzeskowiak","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib102","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12884-017-1334-4","article-title":"Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study","volume":"17","author":"Heller","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2018.05.017_bib103","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdra.20327","article-title":"Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations","volume":"79","author":"K\u00e4ll\u00e9n","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2018.05.017_bib104","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib105","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib106","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First trimester use of selective serotonin reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib107","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.reprotox.2005.11.006","article-title":"Antidepressant drugs during pregnancy and infant congenital heart defect","volume":"21","author":"K\u00e4ll\u00e9n","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2018.05.017_bib108","unstructured":"Paroxetine and pregnancy. GlaxoSmithKline. Updated 2018. Available at: https:\/\/www.gsk.com\/en-gb\/media\/resource-centre\/paroxetine-information\/paroxetine-and-pregnancy. Accessed April 12, 2018."},{"key":"10.1016\/j.ajog.2018.05.017_bib109","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.clinthera.2007.05.003","article-title":"Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors","volume":"29","author":"Bar-Oz","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.ajog.2018.05.017_bib110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdra.20627","article-title":"First trimester paroxetine use the\u00a0prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies","volume":"88","author":"Wurst","year":"2010","journal-title":"Birth Defects Res A"},{"key":"10.1016\/j.ajog.2018.05.017_bib111","doi-asserted-by":"crossref","first-page":"f6932","DOI":"10.1136\/bmj.f6932","article-title":"Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis","volume":"348","author":"Grigoriadis","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.017_bib112","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"9","author":"Chambers","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2018.05.017_bib114","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2018.05.017_bib115","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1176\/appi.ajp.2015.14121575","article-title":"Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data","volume":"172","author":"Malm","year":"2015","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.ajog.2018.05.017_bib116","doi-asserted-by":"crossref","first-page":"e20161165","DOI":"10.1542\/peds.2016-1165","article-title":"Persistent pulmonary hypertension of the newborn in late preterm and term infants in California","volume":"139","author":"Steurer","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2018.05.017_bib117","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1701-2163(16)34157-3","article-title":"Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective serotonin\/norepinephrine reuptake inhibitors","volume":"31","author":"Koren","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2018.05.017_bib118","article-title":"Neonatal adaptation in infants prenatally exposed to antidepressants: clinical monitoring using neonatal abstinence score","volume":"2014","author":"Forsberg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib119","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure","volume":"65","author":"Oberlander","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib121","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"Nulman","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib122","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib123","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.295.12.1389","article-title":"Remissions in maternal depression and child psychopathology: a STAR*D-Child report","volume":"295","author":"Weissman","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2018.05.017_bib124","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2017.1727","article-title":"Association of antidepressant medication use during pregnancy with intellectual disability in offspring","volume":"74","author":"Viktorin","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib125","first-page":"1054","article-title":"Infant neurodevelopment following in utero exposure to antidepressant medication","volume":"102","author":"Austin","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ajog.2018.05.017_bib126","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":"Neurodevelopment of children exposed in utero to antidepressant drugs","volume":"336","author":"Nulman","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib127","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/1471-0528.12821","article-title":"Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway","volume":"121","author":"Skurtveit","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.05.017_bib128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapediatrics.2015.3356","article-title":"Antidepressant use during pregnancy and the risk of autism spectrum disorder in children","volume":"170","author":"Boukhris","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2018.05.017_bib129","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","article-title":"Antidepressant use during pregnancy and childhood autism spectrum disorders","volume":"68","author":"Croen","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib130","doi-asserted-by":"crossref","first-page":"f2059","DOI":"10.1136\/bmj.f2059","article-title":"Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study","volume":"346","author":"Rai","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.017_bib131","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1176\/appi.ajp.2010.10020223","article-title":"The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood","volume":"167","author":"Lichtenstein","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib132","doi-asserted-by":"crossref","first-page":"e1357","DOI":"10.1542\/peds.2007-2296","article-title":"Parental psychiatric disorders associated with autism spectrum disorders in the offspring","volume":"121","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2018.05.017_bib133","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaac.2016.02.013","article-title":"Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study","volume":"55","author":"Malm","year":"2016","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib134","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1038\/tp.2015.190","article-title":"Absence of evidence for increase in risk for autism or attention deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study","author":"Castro","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib135","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1111\/bcp.13382","article-title":"Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies","volume":"83","author":"Kaplan","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib136","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","article-title":"Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism","volume":"369","author":"Hviid","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib137","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S53009","article-title":"Antidepressant exposure in pregnancy and risk of autism spectrum disorders","volume":"5","author":"S\u00f8rensen","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ajog.2018.05.017_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-018-0207-7","article-title":"Association between maternal antidepressant use during pregnancy and autism spectrum disorder: an updated meta-analysis","volume":"9","author":"Zhou","year":"2018","journal-title":"Mol Autism"},{"key":"10.1016\/j.ajog.2018.05.017_bib139","doi-asserted-by":"crossref","first-page":"j2811","DOI":"10.1136\/bmj.j2811","article-title":"Antidepressants during pregnancy and autism in offspring: population based cohort study","volume":"358","author":"Rai","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.017_bib140","unstructured":"Lactmed. Available at: https:\/\/toxnet.nlm.nih.gov\/newtoxnet\/lactmed.htm. Accessed September 24,\u00a02017."},{"key":"10.1016\/j.ajog.2018.05.017_bib141","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.genhosppsych.2012.09.003","article-title":"Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview","volume":"35","author":"Bellantuono","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib142","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","article-title":"Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies","volume":"317","author":"Dolovich","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.017_bib143","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/appi.ps.53.1.39","article-title":"Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant","volume":"53","author":"Iqbal","year":"2002","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.ajog.2018.05.017_bib144","doi-asserted-by":"crossref","first-page":"e002166","DOI":"10.1136\/bmjopen-2012-002166","article-title":"Combined use of selective serotonin reuptake inhibitors and sedatives\/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects: a register study","volume":"3","author":"Reis","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2018.05.017_bib145","doi-asserted-by":"crossref","first-page":"e100996","DOI":"10.1371\/journal.pone.0100996","article-title":"First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population based cohort study","volume":"9","author":"Ban","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib146","series-title":"Management of psychiatric disorders in pregnancy","first-page":"134","article-title":"Panic disorder","author":"March","year":"2001"},{"key":"10.1016\/j.ajog.2018.05.017_bib147","unstructured":"Massachusetts General Hospital. The Ammon-Pinozzotto Center for Women\u2019s Mental Health [database online]. Boston, Massachusetts. Updated January 2018. Available at: https:\/\/womensmentalhealth.org\/posts\/benzodiazepines-and-pregnancy. Accessed December\u00a02017."},{"key":"10.1016\/j.ajog.2018.05.017_bib148","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/ije\/dyq103","article-title":"Preterm birth and psychiatric medication prescription in young adulthood: a Swedish national cohort study","volume":"39","author":"Crump","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2018.05.017_bib149","doi-asserted-by":"crossref","first-page":"579.e1","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib150","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","article-title":"Use of benzodiazepines and benzodiazepine receptor antagonists during pregnancy: neonatal outcome and congenital malformations","volume":"166","author":"Wikner","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2018.05.017_bib151","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapsychiatry.2017.2733","article-title":"Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes","volume":"74","author":"Yonkers","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib152","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/JCP.0b013e3182668568","article-title":"Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy","volume":"32","author":"K\u00e4ll\u00e9n","year":"2012","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib153","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00787-014-0558-3","article-title":"Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review","volume":"23","author":"Marroun","year":"2014","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib154","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF01967827","article-title":"Effects of drug administration in pregnancy on children\u2019s school behavior","volume":"12","author":"Stika","year":"1990","journal-title":"Pharm Weekbl Sci"},{"key":"10.1016\/j.ajog.2018.05.017_bib155","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpeds.2012.03.003","article-title":"Neonatal benzodiazepines exposure during breastfeeding","volume":"161","author":"Kelly","year":"2012","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2018.05.017_bib156","doi-asserted-by":"crossref","first-page":"e0181042","DOI":"10.1371\/journal.pone.0181042","article-title":"Association of prenatal exposure to benzodiazepines and child internalizing problems: a sibling controlled cohort study","volume":"12","author":"Brandlistuen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib157","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00228-014-1797-4","article-title":"Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age","volume":"71","author":"Odsbu","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib158","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40264-016-0479-9","article-title":"The risk of adverse pregnancy outcomes after first trimester exposures to H1 antihistamines: a systematic review and meta-analysis","volume":"40","author":"Etwel","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajog.2018.05.017_bib159","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0022-3476(74)80480-4","article-title":"Probable benadryl withdrawal manifestations in a newborn infant","volume":"85","author":"Parkin","year":"1974","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2018.05.017_bib160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/DDDT.S89485","article-title":"Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Maneeton","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ajog.2018.05.017_bib161","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1176\/appi.ajp.159.1.136","article-title":"Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants","volume":"159","author":"Koren","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib162","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study","volume":"66","author":"McKenna","year":"2005","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib163","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","article-title":"Atypical antipsychotic drugs and pregnancy outcome: a prospective cohort study","volume":"33","author":"Habermann","year":"2013","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib164","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/appi.ajp.2015.15040506","article-title":"Reproductive safety of second-generation antipsychotics: current data from the Massachusetts general hospital pregnancy registry for atypical antipsychotics","volume":"173","author":"Cohen","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib165","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","article-title":"Antipsychotic use in pregnancy and the risk for congenital malformations","volume":"73","author":"Huybrechts","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib166","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib167","unstructured":"FDA Drug Safety Communication: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns [online database]. US Department of health and Human Services. Available at: www.fda.gov\/Drugs\/DrugSafety\/ucm243903.htm. Rockville, MD. Updated August 4, 2017. Accessed April 9, 2018."},{"key":"10.1016\/j.ajog.2018.05.017_bib168","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000491","article-title":"Second-generation antipsychotics during the lactation period: a comparative systematic review on infant safety","volume":"36","author":"Uguz","year":"2016","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib169","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.euroneuro.2016.08.008","article-title":"Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder","volume":"26","author":"Pacchiarotti","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib170","doi-asserted-by":"crossref","first-page":"e003062","DOI":"10.1136\/bmjopen-2013-003062","article-title":"Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study","volume":"3","author":"Sadowski","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2018.05.017_bib171","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?","volume":"116","author":"Lin","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.ajog.2018.05.017_bib172","doi-asserted-by":"crossref","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","article-title":"A\u00a0prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies","volume":"9","author":"Kulkarni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.05.017_bib173","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0447.2012.01897.x","article-title":"Clinical interventions for women with schizophrenia: pregnancy","volume":"127","author":"Seeman","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ajog.2018.05.017_bib174","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.bp.107.041541","article-title":"Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study","volume":"192","author":"Newham","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00213-013-3060-6","article-title":"Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study","volume":"228","author":"Peng","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ajog.2018.05.017_bib176","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","article-title":"Prenatal antipsychotic exposure and neuromotor performance during infancy","volume":"69","author":"Johnson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib177","first-page":"605","article-title":"Use of psychotropic medication during pregnancy and the postpartum period","volume":"9","author":"Pearlstein","year":"2013","journal-title":"Womens Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib178","unstructured":"The National Register of Antipsychotic Medication in Pregnancy [online database]. Melbourne, Australia. Updated 2013. Available at: http:\/\/www.maprc.org.au\/nramp. Accessed November\u00a02017."},{"key":"10.1016\/j.ajog.2018.05.017_bib179","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.bp.108.049585","article-title":"Prescribing in pregnancy","volume":"192","author":"Paton","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib180","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/jwh.2010.2371","article-title":"Relationships among depression, anxiety, and insomnia symptoms in perinatal women seeking mental health treatment","volume":"20","author":"Swanson","year":"2011","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib181","first-page":"1030","article-title":"Transfer of drugs and other chemicals into human milk","volume":"110","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2018.05.017_bib182","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1542\/peds.2013-1985","article-title":"The transfer of drugs and therapeutics into human breast milk: an update on selected topics","volume":"132","author":"Sachs","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2018.05.017_bib183","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.mp.4002007","article-title":"Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications","volume":"13","author":"Oberlander","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib184","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2018.05.017_bib185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.jp.7211640","article-title":"Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram","volume":"27","author":"Potts","year":"2007","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ajog.2018.05.017_bib186","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","article-title":"Perinatal outcome following third trimester exposure to paroxetine","volume":"156","author":"Costei","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib187","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000090929","article-title":"Maternal selective serotonin reuptake inhibitor intake does not seem to affect neonatal platelet function tests","volume":"115","author":"Maayan-Metzger","year":"2006","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ajog.2018.05.017_bib188","first-page":"195","article-title":"Severe paroxetine induced hyponatremia in a breastfed infant","volume":"16","author":"Abdul Aziz","year":"2004","journal-title":"J\u00a0Bahrain Med Soc"},{"key":"10.1016\/j.ajog.2018.05.017_bib189","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674370905400405","article-title":"Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study","volume":"54","author":"Einarson","year":"2009","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib190","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4088\/JCP.15m10506","article-title":"Prenatal psychostimulant and antidepressant exposure and risk of hypertensive disorders of pregnancy","volume":"77","author":"Newport","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib191","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/EDE.0b013e31829e0aaa","article-title":"Antidepressant use and risk for preeclampsia","volume":"24","author":"Palmsten","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2018.05.017_bib192","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/AOG.0000000000001200","article-title":"Postpartum hemorrhage and use of serotonin reuptake inhibitor antidepressants in pregnancy","volume":"127","author":"Hanley","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib193","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archpedi.158.4.312","article-title":"Neonate characteristics after maternal use of antidepressants in late pregnancy","volume":"158","author":"Kallen","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2018.05.017_bib194","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1253\/circj.CJ-15-0617","article-title":"Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease","volume":"80","author":"Tanaka","year":"2016","journal-title":"Circulation J"},{"key":"10.1016\/j.ajog.2018.05.017_bib195","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-3476(77)81049-4","article-title":"Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition","volume":"91","author":"Cottrill","year":"1977","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2018.05.017_bib196","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1471-0528.1978.tb14909.x","article-title":"Propranolol for the treatment of hypertension in pregnancy","volume":"85","author":"Eliahou","year":"1978","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.05.017_bib197","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.2.6138.670","article-title":"Propranolol in hypertension during pregnancy","volume":"2","author":"Tcherdakoff","year":"1978","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.017_bib198","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1471-0528.1980.tb04502.x","article-title":"Propranolol and hydralazine in the management of essential hypertension in pregnancy","volume":"87","author":"Bott-Kanner","year":"1980","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.05.017_bib199","first-page":"792","article-title":"The effect of propranolol on the onset of breathing at birth","volume":"41","author":"Turnstall","year":"1969","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ajog.2018.05.017_bib200","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1471-0528.1975.tb00701.x","article-title":"Use of propranolol in dysfunctional labour","volume":"82","author":"Mitrani","year":"1975","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.05.017_bib201","first-page":"485","article-title":"Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet","volume":"135","author":"Pruyn","year":"1979","journal-title":"Gynecol"},{"key":"10.1016\/j.ajog.2018.05.017_bib202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/JCP.0b013e3182197055","article-title":"Are hypnotic benzodiazepine receptor agonists teratogenic in humans?","volume":"31","author":"Wikner","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2018.05.017_bib203","unstructured":"Reprotox [online database]. Washington DC. Updated 2018. Available at: https:\/\/reprotox.org. Accessed December\u00a02017."},{"key":"10.1016\/j.ajog.2018.05.017_bib204","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/clpt.2010.97","article-title":"Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy","volume":"88","author":"Wang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2018.05.017_bib205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00737-009-0100-7","article-title":"Zolpidem (Ambien) in pregnancy: placental passage and outcome","volume":"12","author":"Juric","year":"2009","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2018.05.017_bib206","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/070674370304800207","article-title":"A\u00a0multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy","volume":"48","author":"Einarson","year":"2003","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.ajog.2018.05.017_bib207","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/074873049701200603","article-title":"Melatonin: role in development","volume":"12","author":"Davis","year":"1997","journal-title":"J\u00a0Biol Rhythms"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:19:28Z","timestamp":1757589568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937818304125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":207,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0002937818304125"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2018.05.017","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perinatal anxiety: approach to diagnosis and management in the obstetric\u00a0setting","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2018.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}